Effects of Plasmapheresis on Aging Biomarkers

NCT05004220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2023-09-06

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of plasmapheresis (repeated plasma withdrawals) on selected health indicators (hematological, biochemical, immunological and indicators of biological age) of plasma donors.

Conditions

  • Aging
  • Plasmapheresis

Interventions

PROCEDURE

Plasmapheresis

Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor.

Sponsors & Collaborators

  • University Hospital Hradec Kralove

    collaborator OTHER
  • Longevitytech.fund a.s.

    collaborator UNKNOWN
  • Clock Foundation

    collaborator UNKNOWN
  • AGECURVE LIMITED

    collaborator UNKNOWN
  • Charles University, Czech Republic

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-06
Primary Completion
2021-08-16
Completion
2023-02-10

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05004220 on ClinicalTrials.gov